ABSI
Price
$10.77
Change
+$0.63 (+6.21%)
Updated
Sep 30 closing price
Capitalization
1.63B
48 days until earnings call
Intraday BUY SELL Signals
CADL
Price
$10.44
Change
-$0.44 (-4.04%)
Updated
Sep 30 closing price
Capitalization
856.24M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs CADL

ABSI vs CADL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABSI vs. CADL commentary
Oct 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Buy and CADL is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ABSICADL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
90%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Oct 01, 2026
Stock price -- (ABSI: $10.77 vs. CADL: $10.44)
Brand notoriety: ABSI and CADL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 163% vs. CADL: 106%
Market capitalization -- ABSI: $1.63B vs. CADL: $856.24M
ABSI [@Biotechnology] is valued at $1.63B. CADL’s [@Biotechnology] market capitalization is $856.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green while CADL’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • CADL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABSI and CADL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while CADL’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 5 bearish.
  • CADL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than CADL.

Price Growth

ABSI (@Biotechnology) experienced а +10.52% price change this week, while CADL (@Biotechnology) price change was -7.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.67%. For the same industry, the average monthly price growth was -10.91%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 17, 2026.

CADL is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABSI
Daily Signal:
Gain/Loss:
CADL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YJ1.74N/A
N/A
Yunji Inc
RRGB7.57-0.08
-1.05%
Red Robin Gourmet Burgers
NMR9.78-0.13
-1.31%
Nomura Holdings
CRK12.32-0.19
-1.52%
Comstock Resources
CRTO15.20-0.25
-1.62%
Criteo SA

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+6.21%
RXRX - ABSI
61%
Loosely correlated
+2.48%
CRSP - ABSI
58%
Loosely correlated
-1.21%
SANA - ABSI
55%
Loosely correlated
+0.17%
ABCL - ABSI
55%
Loosely correlated
-1.55%
BEAM - ABSI
52%
Loosely correlated
-0.29%
More

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with EDIT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-4.04%
EDIT - CADL
45%
Loosely correlated
-0.77%
RXRX - CADL
44%
Loosely correlated
+2.48%
VIR - CADL
43%
Loosely correlated
+4.98%
FDMT - CADL
42%
Loosely correlated
-1.24%
ABSI - CADL
42%
Loosely correlated
+6.21%
More